Institutional Fund
Tang Capital Management LLC
San Diego, CACIK 12326215 filings on record
Portfolio Value
$1.97B
Q1 2026
Holdings
51
Reported positions
New Buys
4
Opened this quarter
QoQ Change
-2.7%
from $2.02B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Aurinia Pharmaceuticals Inc9.2%
- Celcuity Inc6.1%
- Mirum Pharmaceuticals Inc5.8%
- Galapagos NV5.8%
- Spdr S&P 500 ETF Tr5.5%
- Kiniksa Pharmaceuticals Intl5.5%
- Other62.1%
Portfolio Holdings
51 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Aurinia Pharmaceuticals Inc | 12.23M | $181.24M | 9.2% | +900.0K | Added |
| 2 | Celcuity Inc | 1.05M | $119.85M | 6.1% | 0 | Held |
| 3 | Mirum Pharmaceuticals Inc | 1.24M | $114.18M | 5.8% | 0 | Held |
| 4 | Galapagos NV | 3.79M | $113.58M | 5.8% | −135.2K | Reduced |
| 5 | Spdr S&P 500 ETF Tr | 168.0K | $109.26M | 5.5% | +138.0K | Added |
| 6 | Kiniksa Pharmaceuticals Intl | 2.26M | $108.81M | 5.5% | 0 | Held |
| 7 | Capricor Therapeutics Inc | 3.40M | $103.36M | 5.2% | +1.70M | Added |
| 8 | Ptc Therapeutics Inc | 1.50M | $102.19M | 5.2% | 0 | Held |
| 9 | Spyre Therapeutics Inc | 1.89M | $95.44M | 4.8% | 0 | Held |
| 10 | Kalvista Pharmaceuticals Inc | 4.57M | $92.07M | 4.7% | 0 | Held |
41 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio